Automate Your Wheel Strategy on LFMD
With Tiblio's Option Bot, you can configure your own wheel strategy including LFMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFMD
- Rev/Share 5.2351
- Book/Share 0.0086
- PB -126.0392
- Debt/Equity -12.3715
- CurrentRatio 0.7717
- ROIC 0.2657
- MktCap 239932009.0
- FreeCF/Share 0.2988
- PFCF 18.0875
- PE -33.5112
- Debt/Assets 0.2998
- DivYield 0
- ROE 1.5486
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | LFMD | BTIG Research | -- | Buy | $15 | $18 | June 18, 2025 |
| Initiation | LFMD | Lake Street | -- | Buy | -- | $12 | Dec. 10, 2024 |
| Initiation | LFMD | Mizuho | -- | Neutral | -- | $7 | Dec. 4, 2024 |
| Resumed | LFMD | B. Riley Securities | -- | Buy | -- | $11 | Aug. 23, 2024 |
News
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
Published: October 10, 2025 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO , Oct. 10, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.
Read More
October 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against LFMD
Published: October 10, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025.
Read More
LIFEMD DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: October 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: October 08, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Oct. 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit.
Read More
LFMD DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: October 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
Read More
Deadline Alert: LifeMD, Inc. (LFMD) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: October 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
Read More
LifeMD Deadline: LFMD Investors with Losses in Excess of $50K Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
Published: October 06, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline
Published: October 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD (LFMD) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Read More
LIFEMD DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages LifeMD, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: October 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
LIFEMD LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds LifeMD Investors to Contact the Firm Before the October 27th Deadline Regarding Class Action Lawsuit
Published: October 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
LifeMD allegedly overstated its market position and raised 2025 guidance despite rising acquisition costs, leaving investors harmed when truth emerged.
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising --- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Published: October 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
Read More
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: October 01, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Oct. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD). IF YOU SUFFERED A LOSS ON YOUR LIFEMD INVESTMENTS, CLICK HERE BEFORE OCTOBER 27, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Read More
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: September 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: September 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
Read More
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
Published: September 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic ® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month.
Read More
LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman
Published: September 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
Read More
SHAREHOLDER ALERT: Berger Montague Reminds LifeMD, Inc. (NASDAQ: LFMD) Investors of Class Action Lawsuit Deadline
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral
PHILADELPHIA , Sept. 29, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period").
Read More
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman
Published: September 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
Read More
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
Published: September 26, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD
Published: September 26, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
Read More
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: September 25, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , Sept. 25, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: September 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) and certain of its officers.
Read More
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD
Published: September 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
Read More
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD
Published: September 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Read More
LifeMD: Set To Ride A Telehealth Tailwind
Published: September 24, 2025 by: Seeking Alpha
Sentiment: Positive
LifeMD shares nearly halved in price following a missed earnings report, with subscriber retention being a key issue. LifeMD stock trades at a significant discount to HIMS despite similar subscription models and industry tailwinds, so I believe a rerating is on the table. The service is inherently sticky, and subscribers are unlikely to switch. The industry is still young, and telehealth is gaining adoption.
Read More
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Published: September 24, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Sept.
Read More
Deadline Alert: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: September 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”).
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
Published: September 23, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD).
Read More
Lost Money on LifeMD, Inc.(LFMD)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
Published: September 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
Read More
About LifeMD, Inc. (LFMD)
- IPO Date 2008-01-29
- Website https://www.lifemd.com
- Industry Medical - Pharmaceuticals
- CEO Justin Schreiber
- Employees 304